Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy

American Journal of Epidemiology

Volumn 177, Issue 3, 2013, Pages 202-212

  Hsu, Ling I ^a   Chen, Gwo Shing ^b   Lee, Chih Hung ^b,c   Yang, Tse Yen ^a   Chen, Yu Hsin ^a   Wang, Yuan Hung ^f   Hsueh, Yu Mei ^d   Chiou, Hung Yi ^d   Wu, Meei Maan ^a   Chen, Chien Jen ^a,e  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

arsenic; Bowen's disease; cohort study; hyperkeratosis; hyperpigmentation; internal malignancy; non melanoma skin cancer

Indexed keywords

ARSENIC ACID;

ARSENIC; CANCER; COHORT ANALYSIS; PIGMENT; POLLUTION EXPOSURE; RESPIRATORY DISEASE; RISK FACTOR; SKIN DISORDER; SMOKING;

ADULT; AGED; ARTICLE; BLACKFOOT DISEASE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HAZARD RATIO; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PALMOPLANTAR KERATODERMA; PROPORTIONAL HAZARDS MODEL; RESIDENTIAL AREA; SKIN CANCER; SKIN DEFECT; SKIN EXAMINATION; SMOKING; TAIWAN; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; ARSENIC POISONING; BOWEN'S DISEASE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERPIGMENTATION; KERATODERMA, PALMOPLANTAR; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS; SMOKING; SOCIOECONOMIC FACTORS; TAIWAN; URINARY BLADDER NEOPLASMS; WATER POLLUTANTS, CHEMICAL;

TAIWAN;

EID: 84874452750     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws369     Document Type: Article

References (36)

1. Chen CJ. Blackfoot disease [letter]. Lancet. 1990;336(8712): 442.
2. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977;19:109-119. (Pubitemid 8182684)
3. Chen CJ, Chiou HY, Chiang MH, et al. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996;16(4):504-510.
4. Chiou HY, Huang WI, Su CL, et al. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997;28(9): 1717-1723.
5. Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet. 1988;1(8582):414- 415.
6. Tseng WP, Chu HM, How SW, et al. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 1968;40(3):453-463.
7. Hsueh YM, Chiou HY, Huang YL, et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(8):589-596.
8. Wu MM, Kuo TL, Hwang YH, et al. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989; 130(6):1123-1132.
9. Guo X, Fujino Y, Kaneko S, et al. Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China. Mol Cell Biochem. 2001;222(1-2):137-140. (Pubitemid 32910329)
10. Haque R, Mazumder DN, Samanta S, et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology. 2003;14(2):174-182. (Pubitemid 40417104)
11. Tondel M, Rahman M, Magnuson A, et al. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect. 1999;107(9):727-729. (Pubitemid 29478883)
12. Chen CJ, Hsu LI, Wang CH, et al. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol Appl Pharmacol. 2005;206(2):198-206.
13. Ahsan H, Chen Y, Parvez F, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol. 2006; 163(12):1138-1148. (Pubitemid 43987578)
14. Guha Mazumder DN, Haque R, Ghosh N, et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol. 1998;27(5):871-877. (Pubitemid 28504977)
15. Ahsan H, Chen Y, Kibriya MG, et al. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1270-1278. (Pubitemid 46984970)
16. Chen Y, Hall M, Graziano JH, et al. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol Biomarkers Prev. 2007;16(2):207-213. (Pubitemid 46383336)
17. Lindberg AL, Rahman M, Persson LA, et al. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol Appl Pharmacol. 2008;230(1):9-16.
18. Cuzick J, Evans S, Gillman M, et al. Medicinal arsenic and internal malignancies. Br J Cancer. 1982;45(6):904-911. (Pubitemid 12085786)
19. Cuzick J, Harris R, Mortimer PS. Palmar keratoses and cancers of the bladder and lung. Lancet. 1984;1(8376): 530-533. (Pubitemid 14197210)
20. Cuzick J, Sasieni P, Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol. 1992;136(4):417-421.
21. Nakadaira H, Endoh K, Katagiri M, et al. Elevated mortality from lung cancer associated with arsenic exposure for a limited duration. J Occup Environ Med. 2002;44(3):291-299. (Pubitemid 34225571)
22. Chen CJ, Wu MM, Lee SS, et al. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8(5):452-460.
23. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995;55(6):1296-1300.
24. Kuo TL. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Rep Inst Pathol Natl Taiwan Univ. 1964;20:7-13.
25. Lo MC, Hsen YC, Lin BK. Arsenic Content of Underground Water in Taiwan: Second Report. Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation; 1977:1-21.
26. Public Health Association. Standard Methods for the Evaluation of Water and Water Waste 307: Mercuric Bromide Stain Method. Washington, DC: American Public Health Association; 1985.
27. Banerjee M, Sarma N, Biswas R, et al. DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions. Int J Cancer. 2008;123(2): 283-287. (Pubitemid 351842011)
28. Chen Y, Graziano JH, Parvez F, et al. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology. 2006;17(4):459-467. (Pubitemid 44305520)
29. Hsueh YM, Cheng GS, Wu MM, et al. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer. 1995;71(1):109-114.
30. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol. 2004;198(3):394-404. (Pubitemid 38969968)
31. Rossman TG, Uddin AN, Burns FJ, et al. Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies. Environ Health Perspect. 2002; 110(suppl 5):749-752. (Pubitemid 35276860)
32. Chiang HC, Tsou TC. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Toxicol In Vitro. 2009;23(5):897-905.
33. Andrew AS, Burgess JL, Meza MM, et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect. 2006;114(8):1193-1198. (Pubitemid 44184676)
34. Andrew AS, Karagas MR, Hamilton JW. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer. 2003; 104(3):263-268. (Pubitemid 36249807)
35. Huang Y, Zhang J, McHenry KT, et al. Induction of cytoplasmic accumulation of p53: a mechanism for low levels of arsenic exposure to predispose cells for malignant transformation. Cancer Res. 2008;68(22):9131- 9136.
36. Komissarova EV, Rossman TG. Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol Appl Pharmacol. 2010;243(3):399-404.